- Conditions: Heart Failure; Atrial Fibrillation
Interventions: Procedure: AV nodal ablation; Drug: Medical Ventricular Rate Control
Sponsor: University of Adelaide
Not yet recruiting - verified January 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Moxonidine; Drug: Placebo
Sponsor: Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified January 2012 - Condition: Metastatic Melanoma
Intervention: Radiation: Whole Brain Radiotherapy
Sponsors: Australia and New Zealand Melanoma Trials Group; Trans-Tasman Radiation Oncology Group (TROG); Sydney Neuro-Oncology Group
Recruiting - verified January 2012 - Conditions: Malignant Rectal Neoplasm; Recurrent Tumor
Intervention: Radiation: intraoperative radiotherapy
Sponsor: Peter MacCallum Cancer Centre, Australia
Completed - verified December 2011 - Condition: Small Cell Lung Cancer
Intervention: Drug: Lithium
Sponsors: Barwon Health; Victorian Cancer Agency
Not yet recruiting - verified December 2011 - Conditions: Acute Lymphoblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia; Precursor T-Cell Lymphoblastic Leukemia
Interventions: Drug: Decitabine; Drug: Vorinostat; Drug: Vincristine; Drug: Dexamethasone; Drug: Mitoxantrone; Drug: Pegaspargase; Drug: Methotrexate
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Not yet recruiting - verified November 2011 - Condition: Coronary Artery Disease
Interventions: Procedure: High Flow oxygen; Procedure: Room Air
Sponsor: Bayside Health
Not yet recruiting - verified December 2011 - Condition: Depression
Interventions: Other: OxIGen + iCBT; Other: iCBT; Other: Waitlist Control
Sponsors: Alishia Williams; The University of New South Wales
Recruiting - verified December 2011 - Conditions: Vertebral Compression Fractures; Osteoporotic Vertebral Compression Fractures; Acute Vertebral Fractures
Intervention: Procedure: Vertebroplasty
Sponsors: Optimus Clinical Research; Care Fusion
Recruiting - verified November 2011 - Condition: Rheumatoid Arthritis
Intervention:
Sponsors: Optimus Clinical Research; Arthritis Australia, Abbott Australia
Recruiting - verified November 2011 - Conditions: Major Depressive Disorder (MDD); Coronary Heart Disease (CHD); Cardiovascular Disease (CVD)
Interventions: Drug: Valdoxan (agomelatine); Drug: Lexapro (escitalopram)
Sponsor: Baker IDI Heart and Diabetes Institute
Not yet recruiting - verified November 2011 - Conditions: Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA); Drug: recombinant deoxyribonuclease (DNase)
Sponsors: Sir Charles Gairdner Hospital; The University of Western Australia
Not yet recruiting - verified November 2011 - Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
Interventions: Drug: Raloxifene Hydrochloride; Drug: Placebo
Sponsor: The Alfred
Recruiting - verified January 2012 - Condition: Perimenopausal Depression
Intervention: Drug: Tibolone
Sponsor: The Alfred
Recruiting - verified January 2012 - Conditions: Diabetes Mellitus, Type 2; Insulin Resistance
Interventions: Dietary Supplement: Zinc supplements; Dietary Supplement: Omega 3 supplements; Dietary Supplement: Placebo supplements
Sponsor: University of Sydney
Completed - verified January 2012 - Condition: Post-transplantation Lymphoproliferative Disorder
Interventions: Drug: Rituximab; Drug: CHOP
Sponsor: Charite University, Berlin, Germany
Terminated - verified October 2011 - Condition: Septic Shock
Interventions: Drug: Hydrocortisone; Drug: lactose
Sponsors: The George Institute; National Health and Medical Research Council, Australia; Australian and New Zealand Intensive Care Society Clinical Trials Group
Not yet recruiting - verified September 2011 - Condition: Peripheral Arterial Disease
Intervention: Device: stent
Sponsor: Flanders Medical Research Program
Recruiting - verified September 2011 - Condition: Anaesthesia
Intervention: Other: Sedation depth
Sponsor: Melbourne Health
Recruiting - verified October 2011 - Conditions: Smoking; Addiction
Intervention: Drug: Nicabate 21mg Transdermal Nicotine Replacement Therapy (NRT)Patch
Sponsors: The Queen Elizabeth Hospital; Basil Hetzel Institute for Translational Research; University of Adelaide; University of South Australia; Clinical Practice Unit; Therapeutics Research Centre
Recruiting - verified September 2011 - Condition: Major Depressive Episode
Interventions: Drug: Ketamine; Drug: Saline (placebo)
Sponsors: The University of New South Wales; Wesley Hospital, Kogarah
Recruiting - verified November 2011 - Condition: HIV-1-Associated Cognitive Motor Complex
Intervention:
Sponsor: Holdsworth House Medical Practice
Recruiting - verified November 2011 - Conditions: HIV-1 Infection; Cardiovascular Disease
Interventions: Other: Control; Other: Intervention Group
Sponsor: Holdsworth House Medical Practice
Recruiting - verified November 2011 - Conditions: Bronchiolitis Obliterans; Immunosuppression
Interventions: Drug: Tacrolimus; Drug: Cyclosporine
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Completed - verified September 2011 - Condition: Vancomycin Therapy
Intervention: Drug: DEVINE vancomycin regimen
Sponsor: The Canberra Hospital
Recruiting - verified August 2011 - Condition: Abdominal Surgery
Interventions: Other: Liberal fluid therapy; Other: Restrictive fluid therapy
Sponsors: Bayside Health; Australian and New Zealand College of Anaesthetists
Not yet recruiting - verified August 2011 - Condition: Heart Transplantation
Intervention:
Sponsor: Nigel E. Drury
Not yet recruiting - verified August 2011 - Condition: Ulcerative Colitis
Interventions: Drug: Rectal tactolimus; Drug: Placebo
Sponsors: The University of Western Australia; Mater Health Services' Adult Hospital, Brisbane, Qld; Concord Hospital; The Canberra Hospital; Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting - verified August 2011 - Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled TrialCondition: Depression
Intervention: Other: bulletin board
Sponsor: Louise Farrer
Not yet recruiting - verified August 2011 - Condition: Appendicitis
Intervention: Drug: metronidazole and cephalzolin
Sponsors: Monash University; Monash Medical Centre
Not yet recruiting - verified August 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Behavioral: Home-based pulmonary rehabilitation; Behavioral: Hospital-based pulmonary rehabilitation
Sponsors: La Trobe University; The Alfred; Austin Health; Monash University
Not yet recruiting - verified August 2011 - Condition: Urinary Retention
Intervention: Device: clean intermittent self catheterisation single use vs re use
Sponsor: St George Hospital, Australia
Recruiting - verified March 2010 - Conditions: Depressive Disorder; Depression
Intervention: Behavioral: Mood Memo emails
Sponsors: Orygen Youth Health Research Centre; National Health and Medical Research Council, Australia; University of Melbourne; Sidney Myer Fund
Recruiting - verified November 2011 - Condition: Heart Failure
Interventions: Drug: Withdrawal of digoxin; Drug: Digoxin
Sponsor: The Alfred
Not yet recruiting - verified June 2011 - Condition: Healthy Volunteers
Intervention: Drug: OZ439
Sponsors: Medicines for Malaria Venture; AMREP Centre for Clinical Studies, Nucleus Network, 89 Commercial Road, Melbourne, VIC 3004 Australia
Not yet recruiting - verified June 2011 - Condition: Pain
Intervention:
Sponsor: IX Biopharma Pte. Ltd.
Recruiting - verified June 2011 - Conditions: Prostate Cancer (Post Prostatectomy); Anal Cancer; Nasopharyngeal Cancer; Intermediate Risk Prostate Cancer
Intervention: Other: Non-Interventional Study
Sponsor: Trans-Tasman Radiation Oncology Group (TROG)
Recruiting - verified June 2011 - Conditions: Colonic Polyp; Colon Cancer
Intervention: Other: Sample of polyp
Sponsor: Sydney West Area Health Service
Recruiting - verified July 2009 - Condition: Colonic Polyps
Interventions: Procedure: Circumferential Submucosal Incision Resection; Procedure: Endoscopic Muscosal Resection
Sponsor: Sydney West Area Health Service
Recruiting - verified May 2010 - Condition: Adenomatous Polyp of Large Intestine
Intervention: Procedure: Prophylactic use of coagulation therapy
Sponsor: Sydney West Area Health Service
Recruiting - verified January 2011 - Condition: Colonic Polyps
Intervention: Procedure: Endoscopic Mucosal Resection
Sponsor: Sydney West Area Health Service
Recruiting - verified September 2008 - Condition: Perimenopause Depression
Interventions: Drug: Tibolone; Drug: Escitalopram
Sponsor: The Alfred
Recruiting - verified January 2012 - Condition: Critically Injured Mechanically Ventilated Trauma Patients
Interventions: Other: Protective manual hyperinflation; Other: Usual method of MHI
Sponsors: The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified November 2010 - Condition: Burns
Intervention: Other: Intensive exercise
Sponsors: The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified November 2010 - Condition: Sepsis Syndromes
Interventions: Other: Exercise; Other: Usual practice
Sponsors: The University of Queensland; Royal Brisbane and Women's Hospital
Active, not recruiting - verified October 2008 - Conditions: Obesity; Type 2 Diabetes
Intervention: Procedure: Hyperbaric Oxygen Treatment
Sponsor: University of Adelaide
Recruiting - verified March 2011 - Conditions: Abdominal Obesity; Hypertension
Interventions: Drug: Moxonidine; Drug: Irbesartan
Sponsor: Baker IDI Heart and Diabetes Institute
Recruiting - verified February 2012 - Condition: Opioid Dependence
Intervention: Drug: Fentanyl
Sponsor: University of Adelaide
Not yet recruiting - verified May 2011 - Condition: Pressure Ulcers
Intervention: Device: Mepilex Border Dressing
Sponsor: Melbourne Health
Recruiting - verified May 2011 - Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
Sponsors: The Prince Charles Hospital; Mater Medical Research Institute
Recruiting - verified September 2009 - Conditions: Renal Failure; Chronic Renal Insufficiency
Interventions: Device: Inspiratory muscle training (URES HS730); Device: Sham inspiratory muscle training (URES HS730)
Sponsor: The University of Queensland
Active, not recruiting - verified May 2011 - Condition: Acute Hepatitis C
Interventions: Drug: Peginterferon alfa-2a; Drug: Ribavirin
Sponsor: Kirby Institute
Not yet recruiting - verified April 2011 - Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
Sponsors: Murdoch Childrens Research Institute; Friedreich Ataxia Research Alliance
Recruiting - verified February 2011 - Condition: Major Depression
Interventions: Device: Eldith Company - direct current stimulator; Device: Eldith Company - direct current stimulator; Device: Eldith Company - direct current stimulator
Sponsor: The University of New South Wales
Recruiting - verified July 2011 - Condition: Bipolar Disorder
Intervention: Device: Transcranial direct current stimulation (Eldith DC Stimulator)
Sponsor: The University of New South Wales
Recruiting - verified April 2011 - Condition: Cognition
Intervention: Procedure: Transcranial direct current stimulation (tDCS)
Sponsor: The University of New South Wales
Recruiting - verified September 2010 - Condition: Peripheral Arterial Disease
Interventions: Drug: Niacin/Laropiprant combination; Drug: Sugar pill
Sponsors: Bayside Health; National Health and Medical Research Council, Australia
Recruiting - verified July 2011 - Condition: Effects on Learning
Intervention: Device: Transcranial direct current stimulation (tDCS)
Sponsor: The University of New South Wales
Recruiting - verified March 2011 - Condition: Medication Overuse Headache
Interventions: Drug: Ibudilast; Drug: Placebo
Sponsors: University of Adelaide; University of South Australia
Recruiting - verified October 2011 - Conditions: Depression; Healthy
Interventions: Procedure: cTBS-PAS25; Procedure: cTBS-iTBS; Procedure: PAS25; Procedure: iTBS
Sponsor: The University of New South Wales
Recruiting - verified March 2011 - Condition: Post-operative Intercostal Neuralgia
Intervention: Drug: Minocycline
Sponsor: University of Adelaide
Recruiting - verified March 2011 - Conditions: Respiratory Tract Infections; Gastrointestinal Infections
Intervention:
Sponsors: Queensland Children's Medical Research Institute; Royal Brisbane and Women's Hospital
Recruiting - verified June 2011 - Condition: Chronic Kidney Disease
Intervention:
Sponsors: University of Sydney; National Health and Medical Research Council, Australia; Sydney South West Area Health Service; Sydney West Area Health Service
Completed - verified February 2011 - Condition: Huntington's Disease
Intervention:
Sponsors: CHDI Foundation, Inc.; Monash University
Recruiting - verified February 2012 - Condition: Breast Cancer
Interventions: Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsor: International Breast Cancer Study Group
Recruiting - verified August 2011 - Conditions: Acute Myocardial Infarction; Coronary Artery Disease; Oxygen
Interventions: Other: Withholding oxygen in uncomplicated patients with STEMI; Other: Oxygen
Sponsors: Bayside Health; Ambulance Victoria; Monash University - Department of epidemiology and preventitive medicine; Baker IDI Heart and Diabetes Institute; FALCK Foundation
Recruiting - verified October 2011 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsor: The University of New South Wales
Recruiting - verified August 2011 - Condition: Spinal Cord Injury
Interventions: Device: Therastride Treadmill System; Device: FES-assisted cycling; Other: Trunk and upper and lower limb exercises; Other: Upper body strength and fitness program
Sponsors: University of Melbourne; Victorian Neurotrauma Initiative; Life Time Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified August 2010 - Conditions: Depression; Major Depressive Disorder
Interventions: Drug: Oxytocin; Drug: Oxytocin and Tibolone; Drug: Placebo
Sponsors: The Alfred; Monash University
Recruiting - verified January 2012 - Condition: Traumatic Brain Injury
Interventions: Drug: Paracetamol; Drug: 0.9% Sodium Chloride Schedule:
Sponsors: South East Sydney and Illawarra Area Health Service; The George Institute; The University of New South Wales; Royal Brisbane and Women's Hospital
Recruiting - verified May 2010 - Condition: Hyperaldosteronism
Intervention:
Sponsor: University Hospital Padova
Completed - verified December 2011 - Conditions: Multiple Trauma; Critically Ill
Interventions: Dietary Supplement: Dipeptiven; Dietary Supplement: normal saline
Sponsor: Royal Brisbane and Women's Hospital
Recruiting - verified September 2010 - Conditions: Metabolic Syndrome; Diabetes
Intervention: Dietary Supplement: high fat overfeeding
Sponsor: University of Adelaide
Recruiting - verified October 2010 - Conditions: Diabetic Retinopathy; Macular Edema
Interventions: Drug: bevacizumab; Drug: dexamethasone
Sponsors: University of Sydney; National Health and Medical Research Council, Australia
Recruiting - verified February 2011 - Condition: Gestational Hypertension
Interventions: Procedure: Intervention is blood pressure management approach; Procedure: Intervention is blood pressure management approach.
Sponsors: University of British Columbia; Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute
Recruiting - verified December 2011 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsor: The University of New South Wales
Recruiting - verified August 2011 - Conditions: Obesity; Overweight
Interventions: Drug: Moxonidine (Physiotens); Other: Dietary intervention
Sponsor: Baker IDI Heart and Diabetes Institute
Recruiting - verified May 2011 - Condition: Otitis Media
Interventions: Drug: Synflorix; Drug: Prevenar13; Drug: COMBO
Sponsor: Menzies School of Health Research
Recruiting - verified September 2011 - Condition: Out-of-hospital Cardiac Arrest
Intervention: Procedure: PARAMEDIC COOLING
Sponsors: Ambulance Victoria; Western Australian Ambulance Service; South Australian Ambulance Service
Recruiting - verified December 2011 - Condition: Arthroplasty, Replacement, Knee
Interventions: Procedure: Long duration tourniquet; Procedure: Short duration tourniquet
Sponsor: Fairfield Hospital, Australia
Terminated - verified March 2011 - Conditions: Bronchiolitis Obliterans; Lung Transplantation
Intervention: Other: MSC
Sponsors: The Prince Charles Hospital; Cell & Tissue Therapies Western Australia
Recruiting - verified July 2011 - Condition: Delirium
Interventions: Drug: Dexmedetomidine; Drug: Saline placebo
Sponsors: Austin Health; Hospira Pty Ltd
Recruiting - verified May 2010 - Condition: Atrial Fibrillation
Intervention: Procedure: DE-MRI
Sponsor: University of Utah
Enrolling by invitation - verified July 2011 - Condition: Tobacco Use Disorder
Interventions: Drug: Champix; Behavioral: Counselling alone
Sponsor: The Queen Elizabeth Hospital
Active, not recruiting - verified April 2010 - Condition: Ankle Fractures
Interventions: Procedure: Open reduction internal fixation of the ankle; Procedure: Non Operative
Sponsors: The University of New South Wales; Whitlam Orthopaedic Research Centre; CROSSBAT Investigators
Recruiting - verified January 2012 - Conditions: Infant, Premature, Diseases; Bronchopulmonary Dysplasia; Retinopathy of Prematurity; Infant, Newborn, Diseases; Infant, Very Low Birth Weight
Interventions: Procedure: Higher oxygen saturation target range (91%-95%); Procedure: Lower oxygen saturation (85%-89%)
Sponsors: University of Sydney; University of Otago; University of Oxford; University of Pennsylvania; University of California, San Diego
Recruiting - verified August 2011 - Conditions: Reverse Oblique Intertrochanteric Fractures; Reverse Oblique Subtrochanteric Fractures
Interventions: Device: Proximal femur locking plate; Device: Intertrochanteric nail
Sponsor: AO Clinical Investigation and Documentation
Recruiting - verified January 2012 - Condition: Duchenne Muscular Dystrophy
Intervention:
Sponsors: Cooperative International Neuromuscular Research Group; Muscular Dystrophy Association (MDA); Children's Research Institute; Washington University, St. Louis; Royal Children's Hospital; Children's Hospital at Westmead; Centro Clinico Nemo; Carolinas Medical Center
Completed - verified October 2011 - Condition: Schizophrenia, Schizoaffective, or Schizophreniform Disorder
Interventions: Drug: Ondansetron; Drug: Placebo
Sponsors: Bayside Health; Stanley Medical Research Institute; Monash University
Recruiting - verified October 2011 - Condition: Leukemia
Interventions: Drug: PEG-L-asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: mercaptopurine; Drug: methotrexate; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Drug: vindesine; Drug: daunoxome; Drug: fludarabine; Radiation: Radiation Therapy
Sponsors: University of Schleswig-Holstein; Deutsche Krebshilfe e.V., Bonn (Germany); medac GmbH (for drug supply in randomization R2 and R-HR)
Recruiting - verified November 2011 - Conditions: Lymphoma; Diffuse Large B-cell Lymphoma
Interventions: Drug: Lenalidomide; Drug: Placebo
Sponsor: Groupe d'Etude des Lymphomes de l'Adulte - Recherche Clinique
Recruiting - verified June 2011 - Conditions: Cystic Fibrosis; Diabetes
Intervention: Drug: Once-daily insulin detemir
Sponsors: Sydney Children's Hospital; The Children's Hospital at Westmead; John Hunter Children's Hospital
Recruiting - verified July 2011 - Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine; Drug: Placebo
Sponsor: Baker IDI Heart and Diabetes Institute
Recruiting - verified March 2010 - Condition: Crohn Disease
Intervention: Drug: Mesenchymal stromal cells (MSC) for infusion
Sponsors: Royal Perth Hospital; The Queen Elizabeth Hospital
Recruiting - verified July 2011 - Condition: Spinal Cord Injury
Interventions: Device: ReJoyce Workstation; Other: Standard Care
Sponsors: University of Melbourne; Victorian Neurotrauma Initiative; Lifetime Care and Support Authority (NSW); The University of Western Australia
Recruiting - verified March 2010 - Condition: Cancer
Intervention:
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Erasmus Medical Center; Sydney West Area Health Service
Recruiting - verified August 2008 - Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsors: Hamilton Health Sciences Corporation; McMaster University
Recruiting - verified December 2011 - Conditions: Chronic Medical Conditions; Personal Health Records; Electronic Medical Record
Interventions: Device: Electronic (USB) Portable Health File; Device: Paper Portable Health File
Sponsors: St George Hospital, Australia; South Eastern Area Health Service; The University of New South Wales; National Health and Medical Research Council, Australia
Recruiting - verified December 2011 - Conditions: Breast Cancer; CYP2D6 Polymorphism
Intervention: Drug: Tamoxifen
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010 - Condition: Intubation; Difficult
Interventions: Drug: Lignocaine; Drug: Placebo
Sponsor: Queensland Children's Medical Research Institute
Recruiting - verified February 2011 - Condition: Endometrial Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Greenslopes Private Hospital; The University of Queensland; Sullivan and Nicolaides Pathology
Recruiting - verified June 2011 - Conditions: Wegener's Granulomatosis; Microscopic Polyangiitis; Churg Strauss Syndrome; Polyarteritis Nodosa; Giant Cell Arteritis; Takayasu Arteritis
Intervention:
Sponsors: University of Oxford; American College of Rheumatology; The European League Against Rheumatism (EULAR); The Vasculitis foundation
Recruiting - verified January 2012 - Conditions: Paroxysmal Atrial Fibrillation; Pulmonary Vein Isolation; Dormant Pulmonary Vein Conduction
Interventions: Procedure: Additional ablation until elimination of dormant conduction; Procedure: No additional ablation; Procedure: Registry group; Procedure: Usual medical care
Sponsors: Montreal Heart Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified September 2011 - Condition: Heart Failure
Intervention:
Sponsors: Monash University; The Alfred
Active, not recruiting - verified October 2011 - Condition: Out-of-hospital Cardiac Arrest
Interventions: Procedure: Target temperature 36°C; Procedure: Target Temperature 33°C
Sponsors: Niklas Nielsen; Scandinavian Critical Care Trials Group; Copenhagen Trial Unit, Center for Clinical Intervention Research; Lund University; The George Institute of Global Health, Sydney, Australia
Recruiting - verified December 2011 - Condition: Major Depression
Intervention: Device: tDCS (Eldith DC-Stimulator (CE certified))
Sponsor: The University of New South Wales
Recruiting - verified August 2011 - Condition: HIV Infections
Interventions: Drug: Efavirenz; Drug: Efavirenz
Sponsor: Kirby Institute
Recruiting - verified November 2011 - Condition: Traumatic Brain Injury
Interventions: Drug: Epoetin Alfa; Drug: Placebo, Sodium Chloride
Sponsors: Australian and New Zealand Intensive Care Research Centre; National Health and Medical Research Council, Australia; Victorian Neurotrauma Initiative; Australian and New Zealand Intensive Care Society Clinical Trials Group; Monash University
Recruiting - verified September 2011 - Condition: Breast Cancer
Interventions: Other: gas chromatography; Other: laboratory biomarker analysis; Other: mass spectrometry
Sponsor: International Breast Cancer Study Group
Active, not recruiting - verified February 2011 - Condition: Respiratory Tract Infections
Interventions: Other: Parent collection; Other: Healthcare worker home visit
Sponsor: Queensland Children's Medical Research Institute
Active, not recruiting - verified February 2011 - Condition: Cervical Cancer
Intervention: Drug: Licensed quadrivalent HPV vaccine, Gardasil
Sponsors: Murdoch Childrens Research Institute; Brockhoff Foundation Australia; Shepherd Foundation Australia
Completed - verified August 2009 - Condition: Mental Health Help-Seeking
Interventions: Other: Control; Other: Destigmatisation and Mental Health Literacy; Other: Help-seeking list; Other: Feedback
Sponsors: Amelia Gulliver; Australian Institute of Sport
Completed - verified October 2011 - Condition: Living Kidney Donation
Intervention:
Sponsors: Lawson Health Research Institute; Canadian Institutes of Health Research (CIHR)
Recruiting - verified April 2011 - Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid; Drug: Rifampin
Sponsors: McGill University; Canadian Institutes of Health Research (CIHR)
Recruiting - verified June 2011 - Condition: Depression
Interventions: Device: rTMS 5 x weekly; Device: rTMS 3 times weekly
Sponsor: Northside Clinic, Australia
Terminated - verified July 2011 - Conditions: Kidney Failure, Acute; Shock
Interventions: Device: Standard polyamide high flux membrane; Device: High cut-off (super high flux) polyamide membrane
Sponsor: Austin Health
Completed - verified January 2012 - Conditions: Healthy; Obesity
Intervention: Drug: ghrelin
Sponsor: Baker IDI Heart and Diabetes Institute
Completed - verified December 2011 - Condition: Acute Kidney Dysfunction
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsor: Austin Health
Recruiting - verified August 2009 - Condition: Stroke
Interventions: Drug: Tissue Plasminogen Activator (Alteplase); Drug: Placebo
Sponsors: National Stroke Research Institute, Australia; Commonwealth Scientific & Industry Research Organisation; Brain Research Institute; University of Melbourne; Melbourne Health
Recruiting - verified August 2011 - Condition: Acute Kidney Injury
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsor: Austin Health
Recruiting - verified April 2009 - Condition: Major Depressive Disorder
Interventions: Procedure: bilateral ultrabrief ECT; Procedure: bilateral standard ECT; Procedure: right-unilateral ultrabrief ECT; Procedure: right-unilateral standard ECT
Sponsors: The University of New South Wales; Northside Clinic, Australia; The Melbourne Clinic, Australia; St George Hospital, Australia; Wandene Private Hospital, Australia
Recruiting - verified September 2011 - Condition: Heart Failure
Intervention: Other: NGAL kit
Sponsors: The Alfred; Biosite
Recruiting - verified June 2011 - Conditions: Breast Neoplasms; Heart Failure
Intervention:
Sponsor: Royal Prince Alfred Hospital, Sydney, Australia
Recruiting - verified July 2011 - Conditions: Epithelial Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
Intervention: Other: Enteral feeding
Sponsors: Queensland Centre for Gynaecological Cancer; Cancer Australia; The University of Queensland
Recruiting - verified June 2011 - Condition: Central Arterial Pressure
Interventions: Drug: Ivabradine; Drug: Metoprolol; Drug: Placebo
Sponsor: Bayside Health
Withdrawn - verified November 2009 - Condition: Prostate Cancer
Intervention:
Sponsor: Barwon Health
Recruiting - verified August 2011 - Condition: Distal Radius Fractures
Interventions: Procedure: volar locking plating; Procedure: external immobilisation
Sponsors: Mackay Base Hospital; James Cook University, Queensland, Australia
Recruiting - verified July 2010 - Conditions: Liver Fibrosis; Heart Failure
Intervention: Device: FibroScan
Sponsors: Monash University; The Alfred
Completed - verified July 2011 - Conditions: Depressive Disorder, Major; Bipolar Disorder
Intervention: Device: Transcranial direct current stimulation
Sponsor: The University of New South Wales
Completed - verified March 2011 - Condition: Hepatitis B
Intervention: Other: Incentive condition
Sponsor: Kirby Institute
Completed - verified June 2011 - Condition: Depression
Interventions: Behavioral: Self-motivated physical activity; Behavioral: Nutrition; Behavioral: Physical activity researcher contact
Sponsor: Australian National University
Completed - verified December 2011 - Conditions: Intracerebral Hemorrhage; Stroke; Hypertension
Intervention: Other: Blood pressure management policies
Sponsor: The George Institute
Recruiting - verified July 2011 - Conditions: Acute Renal Failure; Sepsis; Septic Shock
Interventions: Drug: Angiotensin II; Drug: Saline placebo
Sponsors: Austin Health; Northern Health and Social Care Trust; Western Hospital, Australia
Recruiting - verified January 2009 - Conditions: Systemic Inflammatory Response Syndrome; Oliguria; Renal Impairment
Interventions: Drug: Sodium bicarbonate; Drug: Placebo
Sponsor: Austin Health
Not yet recruiting - verified July 2009 - Conditions: Tuberculosis; Monitoring, Immunologic
Intervention:
Sponsor: Tuberculosis Network European Trialsgroup
Completed - verified May 2011 - Condition: Major Depressive Episode
Interventions: Drug: Ketamine; Drug: Saline
Sponsors: Northside Clinic, Australia; Wesley Hospitals
Recruiting - verified September 2011 - Conditions: Cardiac Surgery; Cardiopulmonary Bypass
Interventions: Drug: Sodium Bicarbonate; Drug: Sodium Chloride
Sponsor: Austin Health
Recruiting - verified November 2009 - Conditions: Renal Replacement Therapy; Renal Dialysis; End Stage Kidney Disease; End Stage Renal Disease; Uremia
Intervention: Procedure: haemodialysis
Sponsor: The George Institute
Recruiting - verified July 2011 - Condition: Heart Failure
Interventions: Drug: Urotensine II; Drug: Soluble epoxide hydrolase
Sponsor: Monash University
Completed - verified July 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Genetic: DNA methylation analysis; Other: laboratory biomarker analysis; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; Radiation Therapy Oncology Group; Medical Research Council; Cooperative Trials Group for Neuro-Oncology
Recruiting - verified May 2011 - Condition: Cervical Cancer
Interventions: Procedure: Total Abdominal Radical Hysterectomy; Procedure: Total Laparoscopic or Robotic Radical Hysterectomy
Sponsors: Queensland Centre for Gynaecological Cancer; M.D. Anderson Cancer Center
Recruiting - verified June 2011 - Conditions: Female Genital Diseases; Ovarian Cancer; Cervical Cancer; Endometrial Cancer; Vulval Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; The University of Queensland; Royal Brisbane and Women's Hospital; Mater Health Services, Brisbane; Mater Private Hospital; Queensland Institute of Medical Research; Queensland University of Technology; Australia New Zealand Gynaecological Oncology Group; Cancer Australia
Active, not recruiting - verified June 2011 - Condition: Heart Failure
Interventions: Drug: Spironolactone; Drug: Placebo
Sponsors: Monash University; National Heart Foundation, Australia
Recruiting - verified July 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: Low-Risk Therapy; Drug: High-Risk Therapy; Drug: Intermediate-Risk Therapy
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified April 2011 - Conditions: PTLD; Posttransplant Lymphoproliferative Disorder
Interventions: Drug: rituximab monotherapy; Drug: sequential R-CHOP
Sponsor: Charite University, Berlin, Germany
Recruiting - verified October 2011 - Conditions: Type 2 Diabetes; Heart Disease
Intervention: Dietary Supplement: Red Wine
Sponsor: Bayside Health
Terminated - verified May 2011 - Condition: Breast Cancer
Intervention: Drug: letrozole
Sponsor: International Breast Cancer Study Group
Recruiting - verified September 2008 - Condition: Cardiovascular Disease
Intervention:
Sponsor: Monash University
Recruiting - verified July 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Interventions: Biological: bevacizumab; Drug: carboplatin; Drug: paclitaxel; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: quality-of-life assessment
Sponsor: Medical Research Council
Recruiting - verified January 2012 - Condition: Bronchiectasis
Intervention: Drug: Hypertonic saline 6% -
Sponsor: The Alfred
Completed - verified June 2011 - Condition: Pelvic Organ Prolapse
Intervention: Procedure: Pelvic Floor Muscle Training
Sponsors: Glasgow Caledonian University; Chief Scientist Office of the Scottish Government; South Glasgow University Hospitals NHS Trust; University of Aberdeen; University of Otago
Completed - verified February 2010 - Condition: Lung Diseases
Interventions: Drug: Sildenafil; Drug: Placebo
Sponsor: Mercy Hospital for Women, Australia
Active, not recruiting - verified August 2011 - Condition: Rectal Cancer
Interventions: Drug: oxaliplatin; Drug: fluorouracil; Drug: leucovorin; Procedure: External beam radiotherapy
Sponsor: Peter MacCallum Cancer Centre, Australia
Completed - verified September 2011 - Condition: End Stage Kidney Disease
Intervention: Procedure: hemodialysis
Sponsor: Universitaire Ziekenhuizen Leuven
Active, not recruiting - verified September 2011 - Condition: Coronary Artery Disease
Intervention:
Sponsors: Monash University; Royal Brompton & Harefield NHS Foundation Trust; IM Medical Ltd, Melbourne
Recruiting - verified July 2011 - Conditions: Heart Disease; Diabetes
Intervention: Drug: rHDL
Sponsors: Bayside Health; Baker Heart Research Institute
Completed - verified October 2006 - Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
Interventions: Drug: Raloxifene hydrochloride; Other: Lactose Capsules
Sponsors: The Alfred; Stanley Medical Research Institute; National Health and Medical Research Council, Australia
Recruiting - verified February 2011 - Condition: Diabetes Mellitus, Insulin-Dependent
Interventions: Biological: Intranasal insulin; Other: Placebo
Sponsors: Melbourne Health; Diabetes Vaccine Development Centre
Recruiting - verified February 2011 - Condition: Living Kidney Donors
Intervention:
Sponsors: Lawson Health Research Institute; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified April 2011 - Condition: Huntington Disease
Intervention:
Sponsors: HP Therapeutics Foundation; Huntington Study Group
Recruiting - verified March 2011 - Condition: Prostate Cancer
Interventions: Procedure: 7800 cGy/39 fractions in 8 weeks; Procedure: 6000 cGy/20 fractions in 4 weeks
Sponsors: Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting - verified October 2011 - Condition: Breast Cancer
Interventions: Radiation: 3D-CRT APBI; Radiation: WBI
Sponsors: Ontario Clinical Oncology Group (OCOG); Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research Alliance
Active, not recruiting - verified July 2011 - Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Intervention: Drug: erlotinib hydrochloride
Sponsor: European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified October 2007 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cediranib maleate; Drug: paclitaxel; Other: placebo
Sponsor: NCIC Clinical Trials Group
Active, not recruiting - verified August 2011 - Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Pentoxifylline
Sponsor: Cooperative International Neuromuscular Research Group
Completed - verified October 2011 - Conditions: Cerebrovascular Accident; Diabetes; Hyperglycemia
Intervention:
Sponsors: Melbourne Health; National Health and Medical Research Council, Australia
Terminated - verified July 2011 - Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group
Active, not recruiting - verified July 2009 - Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg - Tenofovir 300mg; Drug: Abacavir 600mg - Lamivudine 300mg
Sponsor: Kirby Institute
Completed - verified May 2011 - Conditions: Depression; Depressive Disorder
Interventions: Drug: Folate (400mcg) and Vitamin B12 (100 mcg); Behavioral: mediated physical activity promotion; Behavioral: Mental health literacy; Drug: placebo; Behavioral: Nutrition information; Behavioral: pain and arthritis management information
Sponsors: Australian National University; Australian Government Department of Health and Ageing; University of Sydney; Commonwealth Scientific and Industrial Research Organisation, Australia
Completed - verified September 2011 - Conditions: HIV Infections; Hypersensitivity
Intervention:
Sponsors: The Alfred; National Health and Medical Research Council, Australia; Monash University
Withdrawn - verified January 2012 - Condition: Latent Tuberculosis Infection
Intervention: Drug: Isoniazide (drug), Rifampin (drug)
Sponsors: McGill University; Canadian Institutes of Health Research (CIHR)
Active, not recruiting - verified June 2011 - Condition: Cardiovascular Diseases
Interventions: Behavioral: diet of fish and fruit; Behavioral: fruit and fish; Behavioral: diet only; Behavioral: regular diet
Sponsors: Menzies School of Health Research; The George Institute, Sydney , Australia; Department of Health and Community Services, NT, Australia
Completed - verified March 2009 - Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
Sponsor: Queensland Centre for Gynaecological Cancer
Completed - verified February 2012 - Condition: HIV Infections
Intervention:
Sponsors: The Alfred; National Health and Medical Research Council, Australia
Completed - verified January 2012 - Condition: HIV Infections
Intervention:
Sponsors: The Alfred; National Health and Medical Research Council, Australia
Completed - verified January 2012 - Conditions: Mental Disorders; Mood Disorders; Personality Disorders; Schizophrenia and Disorders With Psychotic Features
Interventions: Procedure: Resource-oriented music therapy; Procedure: Standard care
Sponsors: UNIFOB A/S; The Research Council of Norway; Uni Health; Grieg Academy Music Therapy Research Centre GAMUT; Helse Vest; Helse Førde; Nordfjord Psychiatric Centre; Helse Stavanger HF; Jæren District Psychiatric Centre; Wagner Jauregg Hospital Linz; Sunshine Hospital Melbourne/University of Melbourne
Completed - verified June 2007 - Condition: Patellofemoral Pain Syndrome
Interventions: Procedure: Foot Orthotics; Procedure: Physiotherapy
Sponsors: The University of Queensland; National Health and Medical Research Council, Australia
Active, not recruiting - verified September 2006 - Condition: Prostate Cancer
Interventions: Drug: antiandrogen therapy; Drug: releasing hormone agonist therapy; Procedure: orchiectomy
Sponsor: Peter MacCallum Cancer Centre, Australia
Recruiting - verified June 2009 - Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim; Drug: cisplatin; Drug: cyclophosphamide; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Radiation: radiation therapy
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Condition: Breast Cancer
Intervention: Drug: anastrozole
Sponsors: Queen Mary University of London; International Breast Cancer Study Group
Recruiting - verified April 2008 - Condition: Lymphoma
Interventions: Biological: rituximab; Drug: cisplatin; Drug: cytarabine; Drug: dexamethasone; Drug: gemcitabine hydrochloride; Other: clinical observation
Sponsor: NCIC Clinical Trials Group
Recruiting - verified December 2011 - Condition: Breast Cancer
Interventions: Biological: trastuzumab; Procedure: adjuvant therapy
Sponsors: Breast International Group; European Organization for Research and Treatment of Cancer - EORTC; NCIC Clinical Trials Group; International Breast Cancer Study Group
Active, not recruiting - verified January 2007 - Condition: Prostate Cancer
Intervention: Procedure: quality-of-life assessment
Sponsor: European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified December 2004 - Condition: Pancreatic Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride
Sponsor: NCIC Clinical Trials Group
Completed - verified September 2011 - Condition: Breast Cancer
Interventions: Drug: CAF regimen; Drug: CMF regimen; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: methotrexate; Procedure: adjuvant therapy
Sponsor: International Breast Cancer Study Group
Recruiting - verified September 2008 - Condition: Head and Neck Cancer
Interventions: Biological: epoetin alfa; Radiation: radiation therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; Trans-Tasman Radiation Oncology Group (TROG); Charite University, Berlin, Germany; Groupe Oncologie Radiotherapie Tete et Cou; Radius Hungaricus Oncology Group; Grup per l'Estudi dels Limfomes de Catalunya i Balears
Active, not recruiting - verified June 2006 - Conditions: Colorectal Cancer; Metastatic Cancer
Interventions: Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin; Procedure: adjuvant therapy; Procedure: conventional surgery; Procedure: neoadjuvant therapy
Sponsors: European Organization for Research and Treatment of Cancer - EORTC; Australasian Gastro-Intestinal Trials Group; Arbeitsgruppe Lebermetastasen und Tumoren; Cancer Research UK; Fondation Francaise de Cancerologie Digestive
Active, not recruiting - verified December 2000 - Condition: Melanoma (Skin)
Interventions: Biological: pegylated interferon alfa; Procedure: adjuvant therapy
Sponsor: European Organization for Research and Treatment of Cancer - EORTC
Active, not recruiting - verified October 2000 - Condition: Lung Cancer
Interventions: Drug: cisplatin; Drug: etoposide; Drug: vinblastine sulfate; Drug: vindesine; Drug: vinorelbine tartrate; Radiation: radiation therapy
Sponsor: Institut Gustave Roussy
Active, not recruiting - verified April 2011 - Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
Sponsor: NCIC Clinical Trials Group
Completed - verified August 2011
 |
Join Clinical Trials by University in Australia |
